Accordingly, the American Diabetes Association (ADA) has recently recommended its use for the management of both patients with type 1 (T1DM) and type 2 (T2DM) diabetes mellitus treated with multiple daily insulin injections [16]. The gene discussed is INS; the disease is type 1 diabetes mellitus.